drugset / Trial / NCT02163434

Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum

NCT02163434

RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators will compare the effectiveness of gabapentin to metoclopramide for 1 week among 60 women with hyperemesis gravidarum (HG) in this randomized, double-blinded trial. After completion of the 1-week double-blind phase, subjects will be offered open-label gabapentin with rescue metoclopramide until their symptoms no longer require treatment. Enrollment will occur at the University's at Buffalo, of Rochester and of Wisconsin.

Timeline

Start
2014-06
Primary completion
2019-10
Completion
2019-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1800 mg Oral
Subject Gabapentin Small molecule 2400 mg Oral
Subject Metoclopramide Small molecule 45 mg Oral
Subject Metoclopramide Small molecule 60 mg Oral